Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early eculizumab treatment in pediatric STEC-associated hemolytic uremic syndrome
2014-001169-28Phase 3Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Jul 2014
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in hemolytic uremic syndrome (HUS) comparing Eculizumab with Placebo (2 arms). Primary endpoint: Duration of extrarenal epuration. Started Jul 2014; status: completed.
02
Drugs
eculizumab
03
Conditions
hemolytic uremic syndrome (HUS)
Beyond the preview
Go deeper on 2014-001169-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001169-28.